E.P.T.Q. S100 (1×1ml)

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase blood flow to the treatment site, potentially worsening localized edema and increasing the risk of bruising at the entry points.

Treatment is strictly contraindicated. No clinical safety data exists for the use of cross-linked hyaluronic acid during pregnancy or breastfeeding. We prioritize patient safety and defer all elective aesthetic injections until after the nursing period has concluded.

The formulation contains 24 mg/ml of monophasic cross-linked Hyaluronic Acid and 0.3% Lidocaine hydrochloride. The high HA concentration ensures durability, while the monophasic texture ensures a soft and natural integration.

E.P.T.Q. S100 dosage information

Dosage is individualized based on the depth of the superficial lines and the target area. For perioral rejuvenation or mucosal hydration, a single 1 ml syringe is typically sufficient. Practitioners should evaluate if 0.5 ml of filler is appropriate for subtle refinements before utilizing the full volume. For lip treatments requiring more elastic support, clinicians often compare S100 with Restylane Kysse.

E.P.T.Q. S100 side effects

Common reactions include temporary redness, minor swelling, and localized purple bruising at the injection sites. These effects are generally mild and resolve within 3 to 5 days. To uphold the highest safety standards, practitioners must have Liporase (Hyaluronidase) available in the clinic to manage any unexpected tissue irregularities or emergencies.

E.P.T.Q. S100 mechanism of action

The gel acts by physically filling the superficial dermis, providing immediate mechanical smoothing of fine lines while attracting water molecules to boost local hydration. Its low-viscosity structure is designed to avoid the Tyndall effect, which is a primary concern in under-eye filler complications. For patients with thinning skin, it can be combined with Jalupro HMW to improve long-term dermal density and resilience.

E.P.T.Q. S100 with alcohol

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase blood flow to the treatment site, potentially worsening localized edema and increasing the risk of bruising at the entry points.

E.P.T.Q. S100 during pregnancy

Treatment is strictly contraindicated. No clinical safety data exists for the use of cross-linked hyaluronic acid during pregnancy or breastfeeding. We prioritize patient safety and defer all elective aesthetic injections until after the nursing period has concluded.

E.P.T.Q. S100 active substance

The formulation contains 24 mg/ml of monophasic cross-linked Hyaluronic Acid and 0.3% Lidocaine hydrochloride. The high HA concentration ensures durability, while the monophasic texture ensures a soft and natural integration.

Common reactions include temporary redness, minor swelling, and localized purple bruising at the injection sites. These effects are generally mild and resolve within 3 to 5 days. To uphold the highest safety standards, practitioners must have Liporase (Hyaluronidase) available in the clinic to manage any unexpected tissue irregularities or emergencies.

The gel acts by physically filling the superficial dermis, providing immediate mechanical smoothing of fine lines while attracting water molecules to boost local hydration. Its low-viscosity structure is designed to avoid the Tyndall effect, which is a primary concern in under-eye filler complications. For patients with thinning skin, it can be combined with Jalupro HMW to improve long-term dermal density and resilience.